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Abstract
Background: Viruses are obligate intracellular parasites and rely upon the host cell for different
steps in their life cycles. The characterization of cellular genes required for virus infection and/or
cell killing will be essential for understanding viral life cycles, and may provide cellular targets for
new antiviral therapies.
Results: A gene entrapment approach was used to identify candidate cellular genes that affect
reovirus infection or virus induced cell lysis. Four of the 111 genes disrupted in clones selected for
resistance to infection by reovirus type 1 involved the insulin growth factor-2 (IGF-II) pathway,
including: the mannose-6-phosphate/IGF2 receptor (Igf2r), a protease associated with insulin
growth factor binding protein 5 (Prss11), and the CTCF transcriptional regulator (Ctcf). The
disruption of Ctcf, which encodes a repressor of Igf2, was associated with enhanced Igf2 gene
expression. Plasmids expressing either the IGF-II pro-hormone or IGF-II without the carboxy
terminal extension (E)-peptide sequence independently conferred high levels of cellular resistance
to reovirus infection. Forced IGF-II expression results in a block in virus disassembly. In addition,
Ctcf disruption and forced Igf2 expression both enabled cells to proliferate in soft agar, a phenotype
associated with malignant growth in vivo.
Conclusion: These results indicate that IGF-II, and by inference other components of the IGF-II
signalling pathway, can confer resistance to lytic reovirus infection. This report represents the first
use of gene entrapment to identify host factors affecting virus infection. Concomitant
transformation observed in some virus resistant cells illustrates a potential mechanism of
carcinogenesis associated with chronic virus infection.
Background
Viruses as obligate intracellular parasites rely upon the
host cell for different steps in their life cycle, including
attachment, disassembly, transcription, translation,
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reassembly, and egress. Consequently, characterization of
these cellular processes will be essential for any under-
standing of viral life cycles, and may provide cellular tar-
gets for new antiviral therapies.
The susceptibility to virus infection varies greatly among
different cell types, and virus-resistant cells frequently
emerge post-infection [1-4]. This suggests that host cell
contributions to the virus life cycle, although complex,
have genetic determinants. We therefore used a genetic
approach to identify cellular genes required for infection
by reovirus, a small cytolytic RNA virus that replicates in
the cytoplasm. A gene trap retrovirus was use to create
libraries of rat intestinal epithelial (RIE-1) cell clones in
which each clone contained a single gene disrupted by an
integrated retrovirus. The mutant libraries were then
infected with reovirus, and resistant clones were selected.
We hypothesized that genes mutated by gene entrapment
may confer reovirus resistance as a result of either hap-
loinsufficiency or loss of heterozygosity and could be
identified by characterizing the genes disrupted by the
entrapment vector. From these experiments we have iso-
lated 152 clones and have characterized mutations in 111
different genes, providing potential candidates required
for reovirus infection and/or cell killing. Many of the dis-
rupted genes have known or imputed functions, and sev-
eral are known to function in the same or related
pathways. For example, four mutations affected genes in
the insulin growth factor-2 (IGF-II) pathway, including
genes encoding the IGF-ll/manose-6-phosphate receptor
[5,6] (Igf2r, locus ID 25151), the IGF binding protein 5
protease [7] (Prss11, locus ID 65164, 2 clones), and CTCF
(Ctcf, locus ID 83726), a transcriptional repressor of the
IGF-II gene (Igf2) involved in paternal imprinting.
The frequency of mutations involving the IGF-II pathway
led us to investigate the role of IGF-II in reovirus infection.
Clone 6B72, which contains a mutation in Ctcf [8], was
found to over express Igf2 transcripts, consistent with the
known role of CTCF as a transcriptional repressor of the
Igf2 gene. Moreover, forced expression of IGF-II in RIE-1
cells was sufficient to confer cellular resistance to lytic reo-
virus infection. Enforced IGF-II expression also trans-
formed RIE-1 cells to anchorage independent growth, a
phenotype associated with malignant change. These
results represent the first use of gene entrapment to iden-
tify components of host cell metabolism required for virus
infection and illustrate a potential mechanism of carcino-
genesis associated with chronic virus infection.
Results
Disruption of the CTCF gene results in cells resistant to 
lytic infection by reovirus
Gene entrapment strategies to identify host genes required
virus replication depend on methods to select for virus
resistant clones present at about one in 104–105 muta-
genized cells. Unfortunately, cells persistently infected
with reovirus (PI) can emerge at high frequencies (one in
102–103) and are intrinsically resistant to the virus [9,10].
In preliminary studies, we found that hepa 1/a cells were
not suitable for genetic studies due to the emergence of PI
clones. However, persistently infected rat intestinal epi-
thelial cells (RIE-1) [11,12] were found to require a serum
survival factor and die when placed in serum free media
(Figure 1). In vitro infection of RIE-1 cells with reovirus
also appears to mirror virus replication in the rodent host
[13-15]. Consequently, RIE-1 cells were used in the
present study, and reovirus-resistant clones were selected
in serum-free medium to remove PI survivors. RIE-1 cells
were mutagenized by using the U3NeoSV1 gene trap shut-
tle vector [16] (see Methods) and the resulting libraries of
mutagenized cells were infected with reovirus serotype 1/
Lang at a multiplicity of infection (MOI) of 35, to select
for clones resistant to lytic infection. The isolated clones
did not express reoviral antigens, and did not produce
infectious virus as assessed by plaque assay, suggesting
these reovirus resistant clones were not PI.
Regions of genomic DNA adjacent to the U3NeoSV1 pro-
virus in each virus resistant clone were isolated by plasmid
rescue and sequenced. Altogether, of the 151 isolated
clones, 62% of flanking sequences matched known or pre-
sumptive genes, and an additional 23% were represented
in the public databases of expressed sequence tags
(dbEST) or non-redundant sequences (nr). From the 111
clones matching known or presumptive genes, 10 genes
were represented more than once. Many of the disrupted
genes have known or imputed functions, and several are
known to function in the same or related pathways. For
example, the library included 4 independent mutations
Persistently infected RIE-1 cells fail to survive in serum-free  media Figure 1
Persistently infected RIE-1 cells fail to survive in 
serum-free media. RIE-1 parental cells and cells persist-
ently infected with reovirus type 1 were plated in complete 
medium (FBS+) or in media in which the serum was omitted 
(FBS-). Surviving cells were stained with gentian violet after 7 
days. Darkly staining wells represent cell survival.BMC Cell Biology 2004, 5:32 http://www.biomedcentral.com/1471-2121/5/32
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involving three genes that encoded proteins associated
with the insulin growth factor-2 (IGF-II) signalling path-
way, namely, IGF-ll/manose-6-phosphate receptor [5,6]
(Igf2r, locus ID 25151), the IGF binding protein 5 pro-
tease [7] (Prss11, locus ID 65164, 2 clones), and CTCF
(Ctcf, locus ID 83726), a transcriptional repressor of IGF-
II involved in paternal imprinting [17,18]. The position of
the provirus (clone 6B72) in the first intron of the Ctcf
gene is shown in Figure 2. CTCF differentially represses
maternal  Igf2  gene expression, whereas the imprinted
paternal gene escapes repression due to methylation of
CTCF binding sites [17,18].
Igf2 transcripts induced by CTCF disruption
Considering that four clones had mutations in the IGF-II
pathway, the relationship between the Ctcf mutation in
6B72 cells and the virus resistant phenotype was investi-
gated further. Levels of CTCF protein in 6B72 cells were
reduced by about 50% as assessed by western blot analysis
(Figure 3A), consistent with the disruption of one allele.
Diminished CTCF expression was associated with an
increase in Igf2 transcripts as assessed by Northern blot
hybridization (Figure 3B). In addition, two products were
amplified from 6B72 cells by RT-PCR using primers flank-
ing the IGF-II pro-hormone coding sequence (Figure 3C).
The first product was identical to the rat IGF-II pro-hor-
mone (pro-IGF-II) coding sequence (Accession X17012),
whereas, the second contained 14 additional nucleotides
generated by splicing of exon 2 to an alternative splice
acceptor located 14 nucleotides upstream of the normal
Igf2 exon 3 splice acceptor site. The alternative transcript
is expected to encode a pro-IGF-II protein extending 11
amino acids into the E-peptide sequence ending in a
stretch of 60 amino acids lacking homology with any
known protein (Figure 4).
Resistance to reovirus lytic infection results from increased 
Igf2 expression
The stability of virus resistance in the 6B72 cell was tested
by infecting RIE-1 and 6B72 cells with reovirus type 1 at a
MOI of 10. There was approximately a 10 fold lower titre
of reovirus obtained following infection of 6B72 cells as
compared to RIE-1 cells at 24 hrs. post-infection (4.5 ×
105 versus 5.1 × 106), and the difference was also main-
tained at 48 hours post-infection (data not shown). Addi-
tionally, there was a dramatic difference in the survival of
6B72 cells after being exposed to high titres of reovirus
type 1 (Figure 5).
To determine whether Igf2 confers resistance to reovirus
infections, clones of RIE-1 cells over-expressing the full-
length Igf2  transcript or the splice variant (Igf2sv) were
generated and examined for their capacity to resist lytic
infection. As shown in Figure 5 expression of wild type
Disruption of the Ctcf gene in 6B72 cells Figure 2
Disruption of the Ctcf gene in 6B72 cells. DNA 
sequences flanking the U3NeoSV1 provirus in 6B72 cells 
were cloned and sequenced. The flanking sequences were 
identical to sequences in the rat genome, placing the provirus 
in the first intron of the Ctcf gene (A). Filled and open boxes 
indicate coding and non-coding exons, respectively. Flanking 
sequences 5' of the U3NeoSV1 provirus (B) include the first 
exon (shaded) of the gene.
CTCF and Igf2 expression in RIE-1 and 6B72 cells Figure 3
CTCF and Igf2 expression in RIE-1 and 6B72 cells. 
Levels of CTCF protein were assessed by Western blot anal-
ysis (A), normalized to a β-actin control. Levels of Igf2 tran-
scripts were assessed by Northern blot analysis (B) 
normalized to GAPDH control. Protein content, as assayed 
by western blot analysis and standardized to β-actin was 
decreased in the 6B72 cell clone to 30% of control. Reverse 
transcriptase PCR analysis of Igf2 transcripts (C). The RT-
PCR products (arrows) were separated on a 2% agarose gel, 
revealing an additional transcript in the 6B72 cells. The DNA 
sequence of the larger RT-PCR product (D) revealed an 
alternatively spliced transcript (Igf2sv) generated by splicing of 
exon 2 to a cryptic 3' splice site located 14 nucleotides 
upstream of exon 3.BMC Cell Biology 2004, 5:32 http://www.biomedcentral.com/1471-2121/5/32
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(Igf2), but not the splice variant (Igf2sv) increased the
resistance of RIE-1 cells to reovirus infection by over 100
fold. However, when the Igf2svwas transfected into 6B72
cells, the ability of 6B72 cells to survive infection was
abolished. Expression of the Igf2 gene in an anti-sense ori-
entation caused no significant difference in the capacity of
6B72 cells to resist infection (data not shown). These
studies suggest that increased Igf2 expression in 6B72 cells
is associated with their capacity to resist reovirus
infection, and that the Igf2svencodes a trans-dominant iso-
form that blocks the activity of Igf2.
The IGF-II hormone confers resistance to lytic infection
Igf2 transcripts encode a pro-hormone of 180 amino acids
that is processed to generate the 67-residue IGF-II protein
[19]. Other proteolytic products including the 89-residue
carboxy-terminal E peptide may also be biologically active
[20]. The Igf2sv PCR product also contained a single nucle-
otide substitution (G1393A) that results in the substitu-
tion of a threonine for alanine at position 62 of IGF-II,
Alternatively spliced product contains a single nucleotide pol- ymorphism in the igf2 coding sequence Figure 4
Alternatively spliced product contains a single nucle-
otide polymorphism in the igf2 coding sequence. 
Intron sequences incorporated into the alternatively spliced 
transcript (highlighted in black) alter the translational reading 
frame of the pro-homone downstream of the coding 
sequence of the processed IGF-II protein (italics and bold). 
The Igf2sv PCR product also contained a G to A base substi-
tution (underlined) that replaces alanine with threonine at 
codon 62 (boxed) of the mature hormone.
TGGGGATCCCAGTGGGGAAGTCGATGTTGGTGCTTCTCATCTCTTTGGCC
MGIPVGKSMLVLLISLA 1 7
TTCGCCTTGTGCTGCATCGCTGCTTACCGCCCCAGCGAGACTCTGTGCGGA
FALCCIAAYRPSETLCG 34
GGGGAGCTTGTTGACACGCTTCAGTTTGTCTGTTCGGACCGCGGCTTCTAC
GELVDTLQFVCSDRGFY 51
TTCAGCAGGCCTTCAAGCCGTGCCAACCGTCGCAGCCGTGGCATCGTGGAA
FSRPSSRANRRSRGIVE 68
GAGTGCTGCTTCCGCAGCTGCGACTTGGCCCTCCTGGAGACATACTGTGCC
ECCFRSCDLALLETYCA 85
ACCCCCGCCAAGTCCGAGAGGGACGTGTCTACCTCTCAGGCCGTACTTCCG
TPAKSERDVSTSQAVLP 1 0 2
CACCTCCTCTCCAGGACGACTTCCCCAGATACCCCGTGGGCAAGTTCTTCA
HLLSRTTSPDTPWASSS 1 1 9
AATTCGACACCTGGAGACAGTCCGCGGGACGCCTGCGCAGAGGCCTGCCTG
NSTPGDSPRDACAEACL 1 3 6
CCCTCCTGCGTGCCCGCCGGGGTCGCATGCTTGCCAAAGAGCTCGAAGCGT
PSCVPAGVACLPKSSKR 1 5 3
TCAGAGAGGCCAAGCGCCACCGTCCCCTGATCG
SERPSATVP* 1 6 2
IGF-II modulates reovirus resistance in RIE-1 and 6B72 cells Figure 5
IGF-II modulates reovirus resistance in RIE-1 and 
6B72 cells. RIE-1 and 6B72 cells expressing either the IGF-II 
pro-hormone (proIGF2) or the alternatively spliced tran-
script (IGF2SV, Figure 3D) were challenged with serial dilu-
tions of reovirus type 1 (upper panel), and the surviving cells 
were stained with gentian violet 4 days post-infection. The 
multiplicity of infection (MOI) for each row is indicated. pro-
IGF-II converted RIE-I cells to a reovirus resistant phenotype 
(RIE-1/proIGF2) but had little if any effect on already-resist-
ant 6B72 cells (6B72/proIGF2). Plasmids expressing the alter-
natively spliced Igf2 transcript had no effect on RIE-1 cells 
(RIE-1/IGF2SV) but abrogated virus resistance in 6B72 cells 
(6B72/IGF2SV). The experiment was repeated 3 times. 
Expression of Igf2 transgenes (lower panel) was monitored 
by Northern blot hybridization, and the expression of Igf2 in 
RIE-1 cells is shown for comparison. Expression of Igf2 in 
6B72 is not shown.BMC Cell Biology 2004, 5:32 http://www.biomedcentral.com/1471-2121/5/32
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raising questions about Igf2 sequences that influence reo-
virus resistance. Vectors expressing only the 68-residue
IGF-II protein both with and without the A62T change
were compared for their ability to confer resistance to lytic
infection by reovirus type 1 (Figure 6). The IGF-II expres-
sion vector converted RIE-1 cells to a virus resistant phe-
notype; whereas, the IGF-II62T expression plasmid was
inactive (Figure 6) and did not suppress the resistance of
6B72 cells (data not shown). These results indicate that
virus resistance can be affected by mutations in the IGF-II
coding sequence and downstream sequences, including
the E-peptide, are not required. However, the trans-domi-
nant effects of Igf2sv apparently require alterations to the
carboxy-terminus of the IGF-II pro-hormone.
Over expression of igf2 confers resistance to other reovirus 
sertotypes
RIE-1 cells are intrinsically resistant to infection by reovi-
rus type 3 [13]; therefore, experiments to assess the effects
of IGF-II expression on lytic infection by reovirus type 3,
were performed using murine L-cells. As shown in Figure
7, L-cells expressing Igf2 were significantly more resistant
to both reovirus serotypes than the parental cells,
indicating that the ability of IGF-II to confer resistance to
reovirus infection is not limited to a single cell or virus
type.
IGF-II expressing RIE-1 cell has delayed disassembly of 
virus particle
Previous studies have indicated that proteoytic disassem-
bly of virus particles occurs in the lysosome and requires
the participation of cathepsin B and L that are transported
by the Igf2r gene [21-23]. Igf2 binds to Igf2r resulting in
alteration in cathepsin trafficking [24]. Georgi and col-
leagues showed that directly fluorescentated reovirus
particles dissipated their fluorescent signal coincident
with disassembly of the outer capsid [25]. To determine
whether over expression of igf2 would affect disassembly
of virions, we examined the fate of virus during the first
hours of infection. Purified reovirus type 1 virions were
directly labeled with fluorescein and adsorbed to RIE-1 or
6B72 cells, and the persistence of a fluorescein signal
determined at 2 hrs following virus absorption (fig
8A,8B). The binding of virions to RIE-1 cells and 6B72
cells and initial accumulation of virus particles within
cells was similar, however fluorescence was almost non-
detectable in RIE-1 cells (Figure 8A) whereas it was still
present in 6B72 cells at 2 hrs (Figure 8B). In addition,
western blot analysis of virion proteins 2 hrs following
attachment to cells confirmed the persistence of the σ3
protein in the 6B72 cell clone, but not RIE-1 cells (fig
8C,8D). Therefore, disassembly of virions is altered in the
6B72 cell clone.
IGF-II sequences lacking the E-peptide can convert RIE-1 cells  to a reovirus-resistant phenotype Figure 6
IGF-II sequences lacking the E-peptide can convert 
RIE-1 cells to a reovirus-resistant phenotype. Two 
independent clones of RIE-1 cells transfected with plasmids 
expressing native (IGF-II) and mutant (IGF-IIA62T) proteins 
without the carboxyl terminal extension-peptide (E-peptide) 
were challenged with serial dilutions of reovirus type 1 as 
described in Figure 4. Native IGF-II protected RIE-1 cells 
from reovirus infection (IGF-II(a) and IGF-II(b)), while the IGF-
IIA62T mutant (IGF-IIA62T(a) and IGF-IIA62T(b) did not. Non-
infected RIE-1 cells (C), and infected 6B72, and RIE-1 cells 
were included as controls. Expression of Igf2 transgenes 
(lower panel) was monitored by Northern blot hybridization, 
and the expression of Igf2 in RIE-1 cells is shown for compar-
ison. The native IGF-II (small arrow) is slightly larger than the 
cDNA constructs (larger arrow), whereas the double-sided 
arrow marks the constitutively expressed GAPDH, as shown. 
Expression of Igf2 in 6B72 is not shown.BMC Cell Biology 2004, 5:32 http://www.biomedcentral.com/1471-2121/5/32
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CTCF deficient RIE cells grow in soft agar, a consequence 
of increased Igf2 expression
Accumulating evidence suggests that enhanced IGF-II
expression associated with loss of Igf2 genomic imprint-
ing may promote tumour formation [26,27]. Although
RIE-1 and 6B72 cells appeared to proliferate at similar
rates as assessed by MTS/PMS incorporation (Data not
shown), 6B72 cells that have a disrupted Ctcf gene were
capable of forming colonies in soft agar (Figure 9b). To
assess the role of IGF-II in anchorage-independence, cells
transfected with Igf2 and Igf2sv were tested for their ability
to grow in soft agar. RIE-1 cells transfected with Igf2, but
not Igf2sv formed colonies in soft agar (Figure 9a), whereas
6B72 cells transfected with Igf2sv lost their capacity to pro-
liferate in soft agar as did cells transfected with an anti-
sense Igf2 construct (Figure 9b). The IGF-II62T expression
plasmid had no transforming activity (Figure 9d). On bal-
ance, transforming activities of the different Igf2 plasmids
on RIE-1 and 6B72 cells as assessed by the soft agar assay
were similar to their effects on reovirus resistance,
although the vector expressing only IGF-II was less active
in transforming RIE-1 cells to anchorage independence
than vectors expressing the entire pro-hormone.
The capacity to proliferate in soft agar was not a property
of other reovirus resistant cell clones that contained muta-
tions in the IGF-II pathway. Figure 9 shows that cell clones
with disrupted Igfr or Prss11 genes did not form colonies
in soft agar (Figure 9c). An additional reovirus resistant-
clone with an insert in the Anxa2 (annexin 2) gene, asso-
ciated with cytomegalovirus infection [28] and recog-
nized to bind to the insulin and insulin growth factor
receptor-1 [29], also failed to grow in soft agar (Figure 9c).
Therefore, the capacity to proliferate in soft agar was not a
general property of reovirus-resistant cells, even in clones
that contain mutations in the IGF-II pathway. However, L-
cells also displayed enhanced ability to grow in soft agar
in addition to virus resistance, following enforced Igf2
expression (Figure 10).
Discussion
Insertional mutagenesis provides an approach to identify
genes associated with selectable cellular phenotypes. We
have isolated over 100 potential clones with mutations in
genes that may play roles in the life cycle of reovirus. In
the present study, one clone resistant to reovirus lytic
infection contained a provirus inserted into the gene
encoding the CTCF transcriptional regulator. CTCF
binding motifs are present in many genes, including Igf2
[26], H19 [27], and Myc [8]. However, since 3 other clones
selected for reovirus resistance contained mutations in the
IGF-II pathway, the role of IGF-II in virus-resistance was
investigated further. Reduced expression of the Ctcf gene
was associated with enhanced Igf2  expression in virus-
resistant cells, while forced expression of the Igf2 gene in
the parental RIE-1 line was sufficient to confer resistance
to lytic reovirus infection.
By inference, the recovery of inserts affecting other genes
in the IGF-II signalling pathway suggests that mutations in
multiple genes may affect the same phenotype by acting
on a common pathway. The insert in Igf2r was found to
decrease the expression of the gene as assayed by northern
blot analysis (data not shown). As IGF-II targets the igf2r
to lysosomal degradation, mutations in the genes encod-
ing either the receptor (Igf2r) or its ligand (Igf2) will affect
the activity of the other, and result in a reduced endo-
somal trafficking of hydrolases necessary for reovirus dis-
assembly [24]. Our data indicates there is a decrease in
virus disassembly in 6B72 cells, consistent with a block at
Decreased lytic infection of L-cell clones over expressing the  IGF-II gene Figure 7
Decreased lytic infection of L-cell clones over 
expressing the IGF-II gene. Constitutively expressed 
GAPDH was used to assess loading of RNA in lanes. Survival 
of lytic infection was determined by infecting 105 L-cells or L-
cells expressing the pro-IGF2 transgene with varying concen-
trations of reovirus type 1 (A) or type 3 (B). The multiplicity 
of infectious virus particles per cell (MOI) is indicated for 
each virus serotype. Surviving cells were visualized at 4 (A) 
or 5 days (B) following infection with gentian violet. Trans-
gene expression was determined by northern blot (C). 
Experiments were repeated three times and a representative 
experiment is shown.BMC Cell Biology 2004, 5:32 http://www.biomedcentral.com/1471-2121/5/32
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6B72 cells have delayed disassembly of reovirus type 1 Figure 8
6B72 cells have delayed disassembly of reovirus type 1. Fluorescein-labelled reovirus particles were absorbed to RIE-1 
(A) or 6B72 cells (B). Persistent fluorescence at 2 hours was found in 6B72 cells, but not in RIE-1 cells. Non-replicating reovi-
rus type 1, at 3 × 104 particles per cell, was adsorbed to RIE-1 (C) or 6B72 (D) cells at 4°C, washed and incubated at 37°C for 
2 and 4 hours. Cells were lysed and the state of virus particles determined by western blot. The outer capsid proteins µ1 and 
σ3 are present in the 6B72 cell preparations at 2 and 4 hours, but not in the RIE-1 cells.BMC Cell Biology 2004, 5:32 http://www.biomedcentral.com/1471-2121/5/32
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Anchorage-independent growth phenotypes of RIE-1 cell clones Figure 9
Anchorage-independent growth phenotypes of RIE-1 cell clones. 105 cells were suspended in media containing 1% 
agarose and plated in 6 well culture dishes. RIE-1 cells acquire the ability to grow in soft agar after being transfected with a vec-
tor expressing pro-IGF2 but not the IGF2SV splice-variant (a). The vector inserted in the Ctcf gene (6B72) confers the ability to 
grow in soft agar, but the phenotype is suppressed by expression of IGF2SV (b). Clones selected for reovirus resistance with 
gene trap vectors inserted into the Prss11, Igf2r and Anxa2 genes failed to grow in soft agar (c). RIE-1 cells expressing native 
IGF-II protein without the E-peptide grew in soft agar but the colonies were smaller (d) than produced by pro-IGF-2 (a), while 
the corresponding IGF-IIA62T protein (E-peptide) did not transform RIE-1 cells to anchorage independence (d). Colonies were 
photographed (20×) after 7 days except (d) where the cells were photographed after 10 days.BMC Cell Biology 2004, 5:32 http://www.biomedcentral.com/1471-2121/5/32
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this step in morphogenesis. Further studies will be
required to assess if and how inserts in the Prss11 and Igf2r
genes influence reovirus resistance.
As the entry, disassembly, transcription, translation, and
repacking of viruses share common features; we anticipate
that common cellular pathways will influence infection
by other virus families. Indeed, Igf2r has been implicated
in herpes simplex and zoster virus infection [30,31].
However, the present study is the first to show a direct
connection between Igf2 gene expression and resistance to
lytic virus infection. By using constructs that encode the
mature hormone without the E-peptide, we were able to
show that forced IGF-II expression is sufficient to confer a
reovirus resistant phenotype. These results differ from
other studies in which reovirus replication was enhanced
by treatment of RIE-1 cells with insulin. The latter effect is
presumably caused by enhanced virus replication associ-
ated with cell proliferation [13].
Expression of the Igf2 gene is frequently elevated in com-
mon childhood and adult neoplasms [27,32-38] and has
been associated with tumour progression and metastasis
[39,40]. Igf2 also transformed RIE-1 cells to anchorage-
independence, a phenotype that predicts the potential for
malignant growth in vivo. Virus-resistant 6B72 cells also
grew in soft agar, presumably as a result of enhanced IGF-
II expression. Since plasmids expressing only IGF-II were
less active in transforming RIE-1 cells to anchorage inde-
pendence than vectors expressing the entire pro-hormone,
further study is needed to determine whether the capacity
of RIE-1 cells to proliferate in soft agar is enhanced by the
E-peptide or other products derived from the carboxy ter-
minus of the pro-hormone. In other studies, the E-peptide
enhanced insulin secretion from β-cells [20], and may
play a role in cellular transformation [31].
cDNA clones of an alternatively spliced Igf2  transcript
(Igf2sv), blocked the ability of IGF-II to promote reovirus
resistance and anchorage independent growth in a trans-
dominant manner. The protein coding sequence of
Igf2svcontains a frame shift in the E-peptide region and
lacks a site [20,41] required for the proteolytic processing
of the pro-hormone. The alternative splice site is used very
infrequently [only one EST (AA259833) in dbEST was
similarly spliced] and thus probably plays no physiologi-
cal role. Further studies are planned to determine molec-
ular basis for the dominant negative activity of Igf2sv.
IGF-II increases colony formation of L-cells in soft agar Figure 10
IGF-II increases colony formation of L-cells in soft agar. Forced expression of the rat pro-Igf2 gene (pro-Igf2c) in L-cells 
increases the number of soft-agar colonies by 4 to 5 fold as compared to the L-cell parent, as shown in this representative pho-
tomicrograph at 7 days (10×).BMC Cell Biology 2004, 5:32 http://www.biomedcentral.com/1471-2121/5/32
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6B72 cells were highly resistant to reovirus infection as
determined by virus yield and cell survival at different
times post-infection. Virus resistance was a genetically
selected trait manifested by clonally pure cell populations,
could be conferred by enforced IGF-II expression, and
involved decreases in virus disassembly. Although
decreased virus disassembly is sufficient to explain virus
resistance, we do not exclude the possibility that other
mechanisms may contribute to the resistance of 6B72
cells, since any genetic selection may generate clones with
multiple, independent mutations. The fact that an early
step in infection (uptake/disassembly) is defective in
6B72 cells makes it very difficult to test whether down-
stream steps might also be affected.
While the original impetus of our studies was to under-
stand the replication cycle of intracellular pathogens that
cause acute and chronic infectious diseases, the finding of
cell growth phenotypes associated with virus resistance is
of some interest. It has been proposed that lytic viruses
may used to treat certain malignancies [42-45]. However,
based upon our observations, such therapy may carry a
risk associated with selection of virus resistant cell clones
with enhanced growth/survival potential. Additionally,
chronic infections contribute to the development of a
number of human cancers [46-49]. While the
carcinogenic process is not well understood, cell prolifer-
ation associated with inflammation is also thought to
contribute to tumour promotion [50,51]. The present
study illustrates how carcinogenesis could also be influ-
enced by selection for virus-resistant cells with mutations
in genes affecting cell proliferation or survival.
Conclusions
This is the first reported use of gene entrapment to identify
host genes affecting the susceptibility of cells to virus
infection. These results indicate that IGF-II, and by infer-
ence other components of the IGF-II signaling pathway,
can confer high levels of resistance to lytic reovirus
infection. IGF-II expression specifically blocked virus
disassembly. Ctcf disruption and forced Igf2 expression
both enabled cells to proliferate in soft agar, a phenotype
associated with malignant growth in vivo. Therefore, these
results illustrate a potential indirect mechanism of viral
carcinogenesis by which cells selected to virus resistance
may also have enhanced oncogenic potential.
Methods
Entrapment mutagenesis and selection of reovirus 
resistant clones
To identify genes required for reovirus lytic infection, a
gene trap retrovirus shuttle vector, U3NeoSV1, was used
to generate mutagnized rat intestinal (RIE-1) cells [52].
RIE-1 cells were infected with the gene trap vector at a
multiplicity of infection <0.1, and were selection in media
containing G418 sulfate (0.7 mg/ml) (Clontech, Palo
Alto, CA, USA)[52]. Twenty libraries of mutant RIE-1
cells, each consisting of 104 independent gene entrapment
events, were generated and expanded until each mutant
clone was represented by approximately 103 sibling cells.
These cells were plated at low density and incubated in
serum-free media for 3 days until they became quiescent,
infected overnight with reovirus serotype 1 at a multiplic-
ity of infection of 30 plaque forming units (pfu) per cell.
The infected cells were detached with trypsin, DMEM
medium containing 10% fetal bovine serum (FBS)
(Hyclone Laboratories, Inc., Logan, UT, USA) was added
and the cells were allowed to reattach. After 4–6 hours the
medium was replaced with serum-free medium and the
cells were incubated for several days until only a few cells
remained attached to the culture flask. Cells that survived
the selection were allowed to form colonies that were
expanded for further analysis.
Reovirus stocks and infectivity assays
Reovirus type 1 (Lang) and reovirus type 3 (Dearing) were
previously described [53]. A stock of reovirus that was
passaged twice in L cells was purified [14] and the purified
virus band was fluorescein labelled as previously
described [25]. For some experiments the top component,
consisting of virus particles that are devoid of genome,
was used to study the entry pathway [54].
Survival of parental L- and RIE-1 cells and RIE-1 and L-
cells transfected with Igf2 constructs was determined in
96-well plates seeded at 5 × 104 per well. On the following
day, serial dilutions of reovirus type 1 or type 3 were
added in 100 µl of media and cells were incubated at
37°C and 5%CO2 for 1 hour. Cells were washed three
times in PBS, and fresh media was added containing 0.1%
anti-reovirus antibodies to inhibit secondary infection.
Cells were incubated for 4 to 5 days, and surviving cells
visualized with gentian violet. Studies were repeated a
minimum of three times.
To determine the titre of reovirus present in cells, cells
were frozen and thawed three times and plaque assays
were performed as previously described [14]. Titres of
virus were repeated twice.
Fluorescence microscopy
For experiments involving fluorescein labeled reovirus,
cells were grown on glass slides and fixed following
appropriate times with 4% paraformaldehyde, dehy-
drated, and mounting in cytoseal acrylic resin (Stephens
Scientific, Cornwall NJ, USA) to improve clarity and pre-
vent bleaching. Fluorescence microscopy was performed
using an Axiophot microscope (Carl Zeiss, Inc., Thorn-
wood, NY, USA), with a 40×/1.3 plan Neofluar objective
and fluorescein filter set. Images were captured with aBMC Cell Biology 2004, 5:32 http://www.biomedcentral.com/1471-2121/5/32
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low-light, cooled CCD camera (Micromax, Photometries,
Inc., Tucson, AZ, USA).
Identification of genes disrupted by gene entrapment
To identify the gene disrupted by the vector in clones sur-
viving reovirus infection, the shuttle-vector property of
U3NeoSV1 was utilized. Regions of genomic DNA adja-
cent to the U3NeoSV1 provirus were cloned by plasmid
rescue, and sequenced [52]. Sequencing was done using
an automated sequencer (ABI 3700 DNA Analyzer,
Applied Biosystems, Foster City, CA, USA), and the results
obtained were compared to databases available in the
public domain (BLAST nr, est, and hgts). The probability
of a match to sequences in the databases occurring by
chance alone varies due to interspecies conservation and
the length of the match. Matches to characterized genes
were considered significant if the interspecies matches
had a probability score p <10-5 and involved non-repeti-
tive sequences. As indicated, virtually all of the genes iden-
tified had matches to murine or human gene sequences
with p < 10-10 and rat with p < 10-20.
Igf2 expression was assessed by northern blot hybridization
Total RNA was isolated from cultured cells using Trizole
reagent (Gibco BRL, Gaithersburg, MD, USA). 5 µg of
RNA was separated on 1.2% agarose gel, and transferred
to a nitrocellose membrane. Membranes were hybridized
with random prime-labeled (Strategene, Cedar Creek, TX,
USA) probes corresponding to a full length of Igf2 cDNA
and either glyceraldehyde dehydrogenase (GAPDH) or β-
actin cDNA.
Igf2 cDNA isolation and expression
Rat Igf2 cDNAs were obtained using reverse transcriptase
PCR (RT-PCR). Total RNA was extracted from RIE and
6B72 cells using Trizole reagent (Life Technologies, Rock-
ville, MD, USA). RT was performed on 1 µg of total RNA
(PTC-100 programmable Thermal Controller, MJ
Research. Inc, Watertown, MA, USA). A pair of primers
was designed according to rat sequences:
CTTCCAGGTACCAATGGGGATC (forward) and TTT-
GGTTCACTGATGGTTGCTG (reverse). A 500 bp DNA was
amplified under following conditions: 95°C, 1 min; 40
cycles of 95°C 30 seconds, 60°C 30 seconds and 68°C 3
minutes; 68°C 10 min; 4°C.
Immunoblotting analysis
Cells were washed with PBS and lysed in SDS Lamelli
buffer. Protein concentration was determined using the
bicinchoninc acid protein assay (Sigma-Aldrich Corp., St.
Louis, MO, USA). 20 µg of protein extract was loaded in
each lane of a 10% SDS-PAGE and run at 100 V. Protein
was transferred to a nitrocellulose membrane at 22 V over-
night at 4°C. The membrane was washed three times with
TBST (50 mM Tris pH 7.5, 150 mM NaCI, 0.05 % Tween
20) and then incubated in blocking buffer (TBST and 5%
non fat dry milk, pH 7.5) for 1 hour at room temperature.
The membrane was then incubated with anti-mouse,
CTCF (1:500, BD Transduction laboratories) and β-actin
(1:3000, Sigma-Aldrich Corp., St. Louis, MO, USA) in
blocking buffer overnight at 4°C. Following 3 washes, the
membranes were incubated with goat anti-mouse second-
ary antibody (1:20,000, Jackson ImmunoResearch Labo-
ratories, West Grove, PA, USA) for 1 hour at room
temperature, followed by three 15-min washings.
Immune complexes were visualized by addition of chemi-
luminescence reagent (Renaissance, DuPont NEN, Bos-
ton, MA, USA) and the membrane was exposed to Kodak
XAR-5 film (Eastman Kodak Co., Rochester, NY, USA).
Transfection
Cells were cultured to semi-confluence and plasmids
expressing wild type and variant IGF-II transcripts were
transfected into RIE-1 and 6B72 or L-cells using SuperFect
Reagent (Qiagen, Inc. Valencia, CA, USA) according to the
manufacturer's protocol. After 48 hours, transfected cells
were passaged, 1:10, into medium containing hygromicin
B (selective medium) at a concentration determined to
kill 100% of non-transfected cells (150 mg/ml for RIE-1
and 6B72 cells, 650 mg/ml for L-cells). Cells were main-
tained in selective medium until clones appeared.
Soft agar colony forming assay
Dual layers of sea plaque agarose were made with the bot-
tom layer consisting of a 50:50 mixture of 1.6% agarose
solution 1:1 and 2X medium. The bottom layer was
allowed to set for 4 hours, and then a 50:25:25 solution
consisting of 2X medium, 1.6% stock agarose, and 1X
medium containing cells, at a final concentration of 5000
cells/ml, was vortexed in a conical tube, and 2 ml was
added to each well. Following 30 minutes at room tem-
perature to allow the upper layer to set, plates were
incubated at 37°C, 5% CO2 incubator for 7–10 days and
checked for colony formation by microscopy.
Analysis of viral protein expression in infected cells
Cells were plated at 1.5 × 106 per well in 2 ml of medium
in 6-well plates and allowed to sit over night. Cells were
washed with phosphate-buffered saline (PBS), pH 7.4,
and then infected with reovirus type 1 at the specified
MOI. Virus was allowed to adsorb to cells for 1.5 hours at
4°C, washed twice with serum-free medium and incu-
bated at 37°C and 5% CO2. At the indicated times, cells
were scraped and lysed in Tris lysis buffer (10 mM Tris
[pH 7.5], 2.5 mM MgCI2, 100 mM NaCI, 0.5% Triton x-
100, 1 tablet Protease Inhibitor Cocktail Tablets [Roche
Applied Science, Indianapolis, IN, USA] per 10 ml). After
30 min on ice, Laemmli sample buffer (Bio-Rad Laborato-
ries, Hercules, CA, USA) were added to cell lysate samples
(1:1). Protein samples were loaded in a 12% SDS-PAGEBMC Cell Biology 2004, 5:32 http://www.biomedcentral.com/1471-2121/5/32
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gel and run at 100 V. Protein was transferred to a nitrocel-
lulose membrane at 100 V for 1 hour on ice. The mem-
brane was washed three times with TBST (50 mM Tris pH
7.5, 150 mM NaCI, 0.05 % Tween 20) and then incubated
in blocking buffer (TBST and 5% non fat dry milk, pH 7.5)
for 1 hour at room temperature. The membranes were
then incubated with rabbit anti-reovirus type 1 (1:50) and
β-actin (1:3000, Sigma-Aldrich Corp., St. Louis, MO,
USA) antibodies in blocking buffer overnight at 4°C. Fol-
lowing 3 washes in TBST, the membranes were incubated
with goat anti-rabbit (for reovirus) or goat anti-mouse (β-
actin) secondary antibodies (1:20,000, Jackson
ImmunoResearch Laboratories, West Grove, PA, USA) for
1 hour at room temperature, followed by three 15-min
washes. Immune complexes were visualized by addition
of chemiluminescence reagent (Renaissance, DuPont
NEN, Boston, MA, USA) and the membrane was exposed
to Kodak XAR-5 film (Eastman Kodak Co., Rochester, NY,
USA).
Cell Proliferation Assay
RIE-1, 6B72, or Igf2 transfected RIE-1 or 6B72 cells were
seeded at 5 × 104 per well in 96-well plates, incubated at
37°C and 5% CO2. At 4, 6, 18, 48 hours post plating, 3-
(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-
2-(4-sulfophenyl)-2H-tetrazolium [MTS], and an electron
coupling reagent (phenazine methosulfate, [PMS]) were
added at 20 µl per well (CellTiter 96 Aqueous Non-Radi-
oactiver Cell Proliferation Assay, Promega, Madison, Wl).
Plates were incubated for 2 hours, and then the absorb-
ance was determined at 490 nm. Each set of conditions
was repeated in triplicate.
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